Randomized, sham-controlled, multicenter, pragmatic, trial with open-label extension of PHOENIX to improve glycemic control in adults with type 2 diabetes in a real-world setting
Primary Objective
- To evaluate the efficacy and safety of the digital therapeutic, Phoenix, to improve HbA1c at three (3) and six (6) -months compared to a control group. - To evaluate the long-term effectiveness and impact on health care utilization and medication use between study groups in real-world clinical practice over a pragmatic extension period of an additional 18 months.
This Study is
No Longer Enrolling
Details
Age
Adult
Type of Study
Treatment
Scope
National
Locations
Memorial Hospital Central
Study ID
Protocol Number: 22-0315
More information available at ClinicalTrials.gov: NCT05266625
Categories
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers